Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder [Phase 2]
Phase 2 safety and efficacy study of Janssen's JNJ-42165279 in social anxiety disorder has completed, with results posted on 2021-09-02.
-
FDA approval · 2021-08-27FDA Approved: PAROXETINE — Original Application (Modavar Pharmaceuticals LLC)
FDA approved a generic paroxetine tablet product from Modavar Pharmaceuticals LLC under an original abbreviated new drug application (ANDA 2…
-
FDA approval · 2021-08-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Epic Pharma, LLC)
FDA approved the original application for Venlafaxine hydrochloride (generic) manufactured by Epic Pharma, LLC.
-
FDA approval · 2021-06-30FDA Approved: VENLAFAXINE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original application for venlafaxine from Dr. Reddy's Laboratories, making a generic version of the antidepressant availabl…
-
FDA approval · 2021-06-10FDA Approved: VENLAFAXINE — Original Application (Ascend Laboratories, LLC)
FDA approved a generic venlafaxine product from Ascend Laboratories, LLC under Original Application (ANDA).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder [Phase 2, Phase 3]
Phase 2/Phase 3 trial assessing riluzole for acute anxiolytic effects in adults with social anxiety disorder and performance anxiety; trial …
-
FDA approval · 2021-05-03FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved the original application for sertraline hydrochloride generic by XLCare Pharmaceuticals, enabling a generic version to be marke…
-
CLINICAL_TRIALS withdrawal · 2021-03-24Clinical Trial Update: Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study [Phase 3]
An 8-week phase 3 pilot trial of cannabinoids for anxiety disorders was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Ketamine Infusion for Social Anxiety Disorder [EARLY_Phase 1]
Early Phase 1 clinical trial of ketamine infusion for social anxiety disorder has completed with results posted.
-
FDA approval · 2021-02-16FDA Approved: PAROXETINE — Original Application (Westminster Pharmaceuticals, LLC)
The FDA approved Westminster Pharmaceuticals' generic paroxetine (PAROXETINE) via an Original Application (ANDA213485). It covers indication…
-
FDA approval · 2021-02-06FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.
-
FDA approval · 2020-11-03FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for venlafaxine hydrochloride (generic) under ANDA076565, enabling it…
-
FDA approval · 2020-10-21FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved the generic venlafaxine hydrochloride (venlafaxine) under Original Application for the treatment of major depressive disorder, …
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults [Phase 2]
Phase 2 pilot safety study of MDMA-assisted therapy for social anxiety in autistic adults has completed, with results posted in October 2020…
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: Assessing Mechanisms of Anxiety Reduction in Animal-assisted Interventions [NA]
Completed clinical trial assessing mechanisms of anxiety reduction in animal-assisted interventions; results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-29Clinical Trial Update: The Modular Protocol for Mental Health (MPMH) [Phase 1, Phase 2]
Phase 1 and Phase 2 study of the Modular Protocol for Mental Health (MPMH) completed; investigates treatment approaches for multiple mental …
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Computer-Based Treatment for Social Anxiety Disorder [NA]
A completed clinical trial investigating a computer-based treatment for Social Anxiety Disorder; results posted in 2020.
-
FDA approval · 2020-07-21FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Paroxetine hydrochloride from Apotex Corp., enabling continued marketing of a generic product.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder [EARLY_Phase 1]
Early-phase trial update examining the timing of D-Cycloserine to augment cognitive-behavioral therapy for social anxiety disorder.
-
FDA approval · 2020-04-14FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for venlafaxine by BluePoint Laboratories, expanding its generic availability.
-
FDA approval · 2020-04-14FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride (generic Venlafaxine) by Aurobindo Pharma Limited.
-
FDA approval · 2020-04-10FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for venlafaxine from Alembic Pharmaceuticals.
-
FDA approval · 2020-03-12FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd.)
FDA approved the original application for venlafaxine hydrochloride by Advagen Pharma Ltd., authorizing a generic version of this antidepres…
-
FDA approval · 2020-02-21FDA Approved: SERTRALINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for sertraline from Heritage Pharmaceuticals (d/b/a Avet), signaling approval of a change or additio…
-
FDA approval · 2020-02-21FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride (generic sertraline).